| Dr L Philip Guzman, PHD | |
|
180 Fairfield Ave, Bridgeport, CT 06604-4252 | |
| (203) 394-6529 | |
| (203) 384-8835 |
| Full Name | Dr L Philip Guzman |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 180 Fairfield Ave, Bridgeport, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912069196 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 801 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr L Philip Guzman, PHD 365 Peck Ln, Orange, CT 06477-3335 Ph: (203) 795-6221 | Dr L Philip Guzman, PHD 180 Fairfield Ave, Bridgeport, CT 06604-4252 Ph: (203) 394-6529 |
News Archive
Elizabeth Hopkins, an aspiring physician and pre-medical student in the Charles E. Schmidt College of Science at Florida Atlantic University, has spent more than 640 hours shadowing Hilton Becker, M.D., a local plastic and reconstructive surgeon, and an affiliate professor in FAU's Charles E. Schmidt College of Medicine. Together, with Jeffrey Lind II, M.D., they authored a publication in the current issue of Plastic and Reconstructive Surgery Journal, which describes a revolutionary procedure developed by Becker that is an alternative to radical mastectomy.
Dr. Florian Weinberg, from Prof. Dr. Tilman Brummer's research group at the Institute of Molecular Medicine and Cell Research of the University of Freiburg, joined forces with scientists from the Departments of Clinical Pathology and Medicine I of the University Medical Centre Freiburg and the Kinghorn Cancer Centre/Garvan Insitute in Australia in an international team that has identified a new target for cancer therapy.
Theravance, Inc. announced today that it has earned a milestone payment of $20 million for the U.S. Food and Drug Administration (FDA) approval of VIBATIV (telavancin) and supplying its collaboration partner, Astellas Pharma US, Inc. (Astellas), with the launch inventory for the first commercial sale in the United States.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announced that the first-time-in-man Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated and dosing has begun.
› Verified 7 days ago
Dr. Annemarie Theresa Murphy, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1057 Broad Street, Suite 304, Bridgeport, CT 06604 Phone: 203-895-0311 Fax: 203-366-6525 | |
Dr. Ralph R. Ford Jr., PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1057 Broad St, Bridgeport, CT 06604 Phone: 203-336-3661 Fax: 203-551-7014 | |
Dr. Linda Liefland, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1635 Central Avenue, Southwest Connecticut Mental Health System, Bridgeport, CT 06610 Phone: 203-551-7660 Fax: 203-551-7481 | |
Dr. Sundar Ramaswami, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 1635 Central Avenue, Southwest Connecticut Mental Health System, Bridgeport, CT 06610 Phone: 203-551-7660 Fax: 203-551-7481 | |
Dr. Daniel Wartenberg, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1635 Central Avenue, Southwest Connecticut Mental Health System, Bridgeport, CT 06610 Phone: 203-551-7660 Fax: 203-551-7481 | |
Delia Lebron, PSYCHOLOGIST Psychologist Medicare: Not Enrolled in Medicare Practice Location: 471 Barnum Ave, Bridgeport, CT 06608 Phone: 203-333-6864 Fax: 203-332-0376 | |
Dr. Harry Adamakos, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2157 North Ave, Bridgeport, CT 06604 Phone: 203-335-0345 |